Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung.

Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung.

BACKGROUND: The histologic determinants of survival after surgical resection of stage II nonsmall cell lung cancer are poorly understood. We analyzed the prognostic significance of a number of histologic features after complete resection of T1-2N1M0 nonsmall cell cancer of the lung. METHODS: The ca...

Full description

Bibliographic Details
Main Authors:	Khan, O, Fitzgerald, J, Field, M, Soomro, I, Beggs, F, Morgan, W, Duffy, J
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer.
by: Khan, O, et al.
Published: (2003)

Sublobar resection for clinical stage I nonsmall cell lung cancers
by: Tsai-Wang Huang, et al.
Published: (2017-01-01)

Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective
by: Clemens Aigner, et al.
Published: (2024-03-01)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
by: Arafat Tfayli, et al.
Published: (2020-11-01)

Is major pathologic response sufficient to predict survival in resectable nonsmall‐cell lung cancer patients receiving neoadjuvant chemotherapy?
by: Jing‐Sheng Cai, et al.
Published: (2021-05-01)

The Prognostic Significance of the Histological Types in Patients With Nonsmall Cell Lung Cancer ≤2 cm
by: Bo Hao, et al.
Published: (2021-10-01)

Role of gender in the survival of surgical patients with nonsmall cell lung cancer
by: Nóris C Scaglia, et al.
Published: (2013-01-01)

Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program
by: Hei Y, et al.
Published: (2011-04-01)

Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer
by: Nozomu Motono, et al.
Published: (2021-02-01)

Surgery for nonsmall cell lung cancer
by: Loïc Lang-Lazdunski
Published: (2013-09-01)

Update on nonsmall cell lung cancer
by: G. Zalcman, et al.
Published: (2010-09-01)

Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0–N1 nonsmall cell lung cancer and malignant pleural effusion?
by: Marcello Migliore, et al.
Published: (2019-07-01)

Personalised medicine for nonsmall cell lung cancer
by: Céline Mascaux, et al.
Published: (2017-11-01)

Intraventricular chemotherapy and nonsmall cell lung carcinoma
by: Jamir Pitton Rissardo, et al.
Published: (2019-01-01)

Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer
by: Jian-Long Miao, et al.
Published: (2016-01-01)

Effectiveness of maintenance treatments for nonsmall cell lung cancer
by: Eadens MJ, et al.
Published: (2011-07-01)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
by: Christopher M. Kniese, et al.
Published: (2020-11-01)

Impact of surgical approach on 90-day mortality after lung resection for nonsmall cell lung cancer in high-risk operable patients
by: Harry Etienne, et al.
Published: (2024-01-01)

Elevated expression of G3BP1 associates with YB1 and p‐AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection
by: Hongmei Zheng, et al.
Published: (2019-11-01)

Bronchoplatic surgery in the treatment of patients with nonsmall cell lung cancer
by: A. A. Aksarin, et al.
Published: (2022-03-01)

Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer
by: Liang Ye, et al.
Published: (2017-01-01)

Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
by: Lucio Crinò, et al.
Published: (2014-03-01)

Pattern of bone metastasis in patients with nonsmall cell lung cancer
by: Kunihiko Miyazaki, et al.
Published: (2018-01-01)

Solitary fibular metastasis from nonsmall cell lung carcinoma
by: Mohammad Akram, et al.
Published: (2017-01-01)

How to handle oligometastatic disease in nonsmall cell lung cancer
by: Florian Eichhorn, et al.
Published: (2021-01-01)

Disparate outcomes in nonsmall cell lung cancer by immigration status
by: Brittney Chau, et al.
Published: (2021-04-01)

Incidental detection by computed tomography is an independent prognostic factor for survival in patients operated for nonsmall cell lung carcinoma
by: Andri W. Orrason, et al.
Published: (2017-04-01)

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
by: J.B. Sorensen, et al.
Published: (2011-03-01)

Prognosis analysis according to the predominant histological pattern in cases with lung adenocarcinoma undergoing complete resection
by: Murat Kavas, et al.
Published: (2022-06-01)

Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens
by: Lukas Bubendorf, et al.
Published: (2017-06-01)

Ceritinib in the treatment of ALK-positive patients with nonsmall-cell lung cancer
by: K. K. Laktionov, et al.
Published: (2019-06-01)

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
by: Markus Glatzer, et al.
Published: (2016-03-01)

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
by: Rudolf M. Huber, et al.
Published: (2019-07-01)

The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer
by: C.L. Watkins, et al.
Published: (2010-09-01)

Shenyi capsule prolongs postoperative survival of patients with nonsmall cell lung cancer: A multicenter, randomized, controlled trial
by: Dao-Rui Li, et al.
Published: (2023-01-01)

Prospective Analysis on Survival Outcomes of Nonsmall Cell Lung Cancer Stages over IIIb Treated with HangAm-Dan
by: Tae-Young JEONG, et al.
Published: (2010-11-01)

Predicting Outcomes of Nonsmall Cell Lung Cancer Using CT Image Features
by: Samuel H. Hawkins, et al.
Published: (2014-01-01)

The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival
by: Tantraworasin A, et al.
Published: (2013-10-01)

Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
by: Steven F Powell, et al.
Published: (2009-06-01)

Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancer
by: Zoe Hall, et al.
Published: (2020-11-01)